Loading…
Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations
Summary Purpose: STXBP1 (MUNC18‐1) mutations have been associated with various types of epilepsies, mostly beginning early in life. To refine the phenotype associated with STXBP1 aberrations in early onset epileptic syndromes, we studied this gene in a cohort of patients with early onset epileptic...
Saved in:
Published in: | Epilepsia (Copenhagen) 2011-10, Vol.52 (10), p.1828-1834 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4631-68a75bdfd80518bbd00e939e88a049a74f73baf41c8c9df88b9962d339b94bd13 |
---|---|
cites | |
container_end_page | 1834 |
container_issue | 10 |
container_start_page | 1828 |
container_title | Epilepsia (Copenhagen) |
container_volume | 52 |
creator | Milh, Mathieu Villeneuve, Nathalie Chouchane, Mondher Kaminska, Anna Laroche, Cécile Barthez, Marie Anne Gitiaux, Cyril Bartoli, Céline Borges‐Correia, Ana Cacciagli, Pierre Mignon‐Ravix, Cécile Cuberos, Hélène Chabrol, Brigitte Villard, Laurent |
description | Summary
Purpose: STXBP1 (MUNC18‐1) mutations have been associated with various types of epilepsies, mostly beginning early in life. To refine the phenotype associated with STXBP1 aberrations in early onset epileptic syndromes, we studied this gene in a cohort of patients with early onset epileptic encephalopathy.
Methods: STXBP1 was screened in a multicenter cohort of 52 patients with early onset epilepsy (first seizure observed before the age of 3 months), no cortical malformation on brain magnetic resonance imaging (MRI), and negative metabolic screening. Three groups of patients could be distinguished in this cohort: (1) Ohtahara syndromes (n = 38); (2) early myoclonic encephalopathies (n = 7); and (3) early onset epileptic encephalopathies that did not match any familiar syndrome (n = 7). None of the patients displayed any cortical malformation on brain MRI and all were screened through multiple video–electroencephalography (EEG) recordings for a time period spanning from birth to their sixth postnatal month. Subsequently, patients had standard EEG or video‐EEG recordings.
Key Findings: We found five novel STXBP1 mutations in patients for whom video‐EEG recordings could be sampled from the beginning of the disease. All patients with a mutation displayed Ohtahara syndrome, since most early seizures could be classified as epileptic spasms and since the silent EEG periods were on average shorter than bursts. However, each patient in addition displayed a particular clinical and EEG feature: In two patients, early seizures were clonic, with very early EEG studies exhibiting relatively low amplitude bursts of activity before progressing into a typical suppression‐burst pattern, whereas the three other patients displayed epileptic spasms associated with typical suppression‐burst patterns starting from the early recordings. Epilepsy dramatically improved after 6 months and finally disappeared before the end of the first year of life for four patients; the remaining one patient had few seizures until 18 months of age. In parallel, EEG paroxysmal abnormalities disappeared in three patients and decreased in two, giving place to continuous activity with fast rhythms. Each patient displayed frequent nonepileptic movement disorders that could easily be mistaken for epileptic seizures. These movements could be observed as early as the neonatal period and, unlike seizures, persisted during all the follow‐up period.
Significance: We confirm that STXBP1 is a major g |
doi_str_mv | 10.1111/j.1528-1167.2011.03181.x |
format | article |
fullrecord | <record><control><sourceid>proquest_hal_p</sourceid><recordid>TN_cdi_hal_primary_oai_HAL_hal_01668681v1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3278081061</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4631-68a75bdfd80518bbd00e939e88a049a74f73baf41c8c9df88b9962d339b94bd13</originalsourceid><addsrcrecordid>eNqFkk1r3DAQhkVJaTZJ_0IQ5BB6sDtj2fo49JAs2ySw0IUm0JuQbZn14pVdy26y_75ydrOBXqqLxMyjl5l5hxCKEGM4XzcxZomMELmIE0CMgaHE-OUDmR0TJ2QGgCxSmYRTcub9BgAEF-wTOU1QCFBJOiNu0dWN7Ya6oMaV1LXOHgOVNcPYW09rRzsz1NYNnj7Xw5pa0zc72jpvB_rOW1fYbm2aNsDr3avez8dftyuk23EI_wN_QT5WpvH28-E-J0_fF4_z-2j54-5hfrOMipQzjLg0IsvLqpSQoczzEsAqpqyUBlJlRFoJlpsqxUIWqqykzJXiScmYylWal8jOyZe9bihHd329Nf1Ot6bW9zdLPcUAOZdc4p-Jvd6zXd_-Hq0f9Lb2hW0a42w7eq3CxDNMk-z_JCQSJDIZyKt_yE079i60rIOWSJjgMFGXB2rMt7Y8FvpmTwC-7YHnMOPdMY-gpzXQGz25rSe39bQG-nUN9IterB6mF_sLakuk2w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1517237608</pqid></control><display><type>article</type><title>Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations</title><source>Wiley</source><creator>Milh, Mathieu ; Villeneuve, Nathalie ; Chouchane, Mondher ; Kaminska, Anna ; Laroche, Cécile ; Barthez, Marie Anne ; Gitiaux, Cyril ; Bartoli, Céline ; Borges‐Correia, Ana ; Cacciagli, Pierre ; Mignon‐Ravix, Cécile ; Cuberos, Hélène ; Chabrol, Brigitte ; Villard, Laurent</creator><creatorcontrib>Milh, Mathieu ; Villeneuve, Nathalie ; Chouchane, Mondher ; Kaminska, Anna ; Laroche, Cécile ; Barthez, Marie Anne ; Gitiaux, Cyril ; Bartoli, Céline ; Borges‐Correia, Ana ; Cacciagli, Pierre ; Mignon‐Ravix, Cécile ; Cuberos, Hélène ; Chabrol, Brigitte ; Villard, Laurent</creatorcontrib><description>Summary
Purpose: STXBP1 (MUNC18‐1) mutations have been associated with various types of epilepsies, mostly beginning early in life. To refine the phenotype associated with STXBP1 aberrations in early onset epileptic syndromes, we studied this gene in a cohort of patients with early onset epileptic encephalopathy.
Methods: STXBP1 was screened in a multicenter cohort of 52 patients with early onset epilepsy (first seizure observed before the age of 3 months), no cortical malformation on brain magnetic resonance imaging (MRI), and negative metabolic screening. Three groups of patients could be distinguished in this cohort: (1) Ohtahara syndromes (n = 38); (2) early myoclonic encephalopathies (n = 7); and (3) early onset epileptic encephalopathies that did not match any familiar syndrome (n = 7). None of the patients displayed any cortical malformation on brain MRI and all were screened through multiple video–electroencephalography (EEG) recordings for a time period spanning from birth to their sixth postnatal month. Subsequently, patients had standard EEG or video‐EEG recordings.
Key Findings: We found five novel STXBP1 mutations in patients for whom video‐EEG recordings could be sampled from the beginning of the disease. All patients with a mutation displayed Ohtahara syndrome, since most early seizures could be classified as epileptic spasms and since the silent EEG periods were on average shorter than bursts. However, each patient in addition displayed a particular clinical and EEG feature: In two patients, early seizures were clonic, with very early EEG studies exhibiting relatively low amplitude bursts of activity before progressing into a typical suppression‐burst pattern, whereas the three other patients displayed epileptic spasms associated with typical suppression‐burst patterns starting from the early recordings. Epilepsy dramatically improved after 6 months and finally disappeared before the end of the first year of life for four patients; the remaining one patient had few seizures until 18 months of age. In parallel, EEG paroxysmal abnormalities disappeared in three patients and decreased in two, giving place to continuous activity with fast rhythms. Each patient displayed frequent nonepileptic movement disorders that could easily be mistaken for epileptic seizures. These movements could be observed as early as the neonatal period and, unlike seizures, persisted during all the follow‐up period.
Significance: We confirm that STXBP1 is a major gene to screen in cases of Ohtahara syndrome, since it is mutated in >10% of the Ohtahara patients within our cohort. This gene should particularly be tested in the case of a surprising evolution of the patient condition if epileptic seizures and EEG paroxysmal activity disappear and are replaced by fast rhythms after the end of the first postnatal year.</description><identifier>ISSN: 0013-9580</identifier><identifier>EISSN: 1528-1167</identifier><identifier>EISSN: 1528-1157</identifier><identifier>DOI: 10.1111/j.1528-1167.2011.03181.x</identifier><identifier>PMID: 21770924</identifier><identifier>CODEN: EPILAK</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Age ; Age of Onset ; Anticonvulsants - therapeutic use ; Birth ; Brain ; Brain - pathology ; Brain - physiopathology ; Cortex ; EEG ; Electroencephalography ; Encephalopathy ; Encephalopathy Ohtahara ; Epilepsy ; Epilepsy - drug therapy ; Epilepsy - genetics ; Epilepsy - pathology ; Epilepsy - physiopathology ; Evolution ; Evolutionary genetics ; Genetic ; Genetics ; Genotype ; Human health and pathology ; Humans ; Infant ; Infant, Newborn ; Life Sciences ; Magnetic Resonance Imaging ; Movement disorders ; Munc18 Proteins - genetics ; Mutation ; Neonates ; Neuroimaging ; Neurons and Cognition ; NMR ; Nuclear magnetic resonance ; Oligonucleotide Array Sequence Analysis ; Rhythms ; Seizures ; Suppression‐burst ; Syndrome</subject><ispartof>Epilepsia (Copenhagen), 2011-10, Vol.52 (10), p.1828-1834</ispartof><rights>Wiley Periodicals, Inc. © 2011 International League Against Epilepsy</rights><rights>Wiley Periodicals, Inc. © 2011 International League Against Epilepsy.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4631-68a75bdfd80518bbd00e939e88a049a74f73baf41c8c9df88b9962d339b94bd13</citedby><orcidid>0000-0002-2190-6843 ; 0000-0001-6657-5008</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21770924$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://amu.hal.science/hal-01668681$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Milh, Mathieu</creatorcontrib><creatorcontrib>Villeneuve, Nathalie</creatorcontrib><creatorcontrib>Chouchane, Mondher</creatorcontrib><creatorcontrib>Kaminska, Anna</creatorcontrib><creatorcontrib>Laroche, Cécile</creatorcontrib><creatorcontrib>Barthez, Marie Anne</creatorcontrib><creatorcontrib>Gitiaux, Cyril</creatorcontrib><creatorcontrib>Bartoli, Céline</creatorcontrib><creatorcontrib>Borges‐Correia, Ana</creatorcontrib><creatorcontrib>Cacciagli, Pierre</creatorcontrib><creatorcontrib>Mignon‐Ravix, Cécile</creatorcontrib><creatorcontrib>Cuberos, Hélène</creatorcontrib><creatorcontrib>Chabrol, Brigitte</creatorcontrib><creatorcontrib>Villard, Laurent</creatorcontrib><title>Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations</title><title>Epilepsia (Copenhagen)</title><addtitle>Epilepsia</addtitle><description>Summary
Purpose: STXBP1 (MUNC18‐1) mutations have been associated with various types of epilepsies, mostly beginning early in life. To refine the phenotype associated with STXBP1 aberrations in early onset epileptic syndromes, we studied this gene in a cohort of patients with early onset epileptic encephalopathy.
Methods: STXBP1 was screened in a multicenter cohort of 52 patients with early onset epilepsy (first seizure observed before the age of 3 months), no cortical malformation on brain magnetic resonance imaging (MRI), and negative metabolic screening. Three groups of patients could be distinguished in this cohort: (1) Ohtahara syndromes (n = 38); (2) early myoclonic encephalopathies (n = 7); and (3) early onset epileptic encephalopathies that did not match any familiar syndrome (n = 7). None of the patients displayed any cortical malformation on brain MRI and all were screened through multiple video–electroencephalography (EEG) recordings for a time period spanning from birth to their sixth postnatal month. Subsequently, patients had standard EEG or video‐EEG recordings.
Key Findings: We found five novel STXBP1 mutations in patients for whom video‐EEG recordings could be sampled from the beginning of the disease. All patients with a mutation displayed Ohtahara syndrome, since most early seizures could be classified as epileptic spasms and since the silent EEG periods were on average shorter than bursts. However, each patient in addition displayed a particular clinical and EEG feature: In two patients, early seizures were clonic, with very early EEG studies exhibiting relatively low amplitude bursts of activity before progressing into a typical suppression‐burst pattern, whereas the three other patients displayed epileptic spasms associated with typical suppression‐burst patterns starting from the early recordings. Epilepsy dramatically improved after 6 months and finally disappeared before the end of the first year of life for four patients; the remaining one patient had few seizures until 18 months of age. In parallel, EEG paroxysmal abnormalities disappeared in three patients and decreased in two, giving place to continuous activity with fast rhythms. Each patient displayed frequent nonepileptic movement disorders that could easily be mistaken for epileptic seizures. These movements could be observed as early as the neonatal period and, unlike seizures, persisted during all the follow‐up period.
Significance: We confirm that STXBP1 is a major gene to screen in cases of Ohtahara syndrome, since it is mutated in >10% of the Ohtahara patients within our cohort. This gene should particularly be tested in the case of a surprising evolution of the patient condition if epileptic seizures and EEG paroxysmal activity disappear and are replaced by fast rhythms after the end of the first postnatal year.</description><subject>Age</subject><subject>Age of Onset</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Birth</subject><subject>Brain</subject><subject>Brain - pathology</subject><subject>Brain - physiopathology</subject><subject>Cortex</subject><subject>EEG</subject><subject>Electroencephalography</subject><subject>Encephalopathy</subject><subject>Encephalopathy Ohtahara</subject><subject>Epilepsy</subject><subject>Epilepsy - drug therapy</subject><subject>Epilepsy - genetics</subject><subject>Epilepsy - pathology</subject><subject>Epilepsy - physiopathology</subject><subject>Evolution</subject><subject>Evolutionary genetics</subject><subject>Genetic</subject><subject>Genetics</subject><subject>Genotype</subject><subject>Human health and pathology</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>Life Sciences</subject><subject>Magnetic Resonance Imaging</subject><subject>Movement disorders</subject><subject>Munc18 Proteins - genetics</subject><subject>Mutation</subject><subject>Neonates</subject><subject>Neuroimaging</subject><subject>Neurons and Cognition</subject><subject>NMR</subject><subject>Nuclear magnetic resonance</subject><subject>Oligonucleotide Array Sequence Analysis</subject><subject>Rhythms</subject><subject>Seizures</subject><subject>Suppression‐burst</subject><subject>Syndrome</subject><issn>0013-9580</issn><issn>1528-1167</issn><issn>1528-1157</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqFkk1r3DAQhkVJaTZJ_0IQ5BB6sDtj2fo49JAs2ySw0IUm0JuQbZn14pVdy26y_75ydrOBXqqLxMyjl5l5hxCKEGM4XzcxZomMELmIE0CMgaHE-OUDmR0TJ2QGgCxSmYRTcub9BgAEF-wTOU1QCFBJOiNu0dWN7Ya6oMaV1LXOHgOVNcPYW09rRzsz1NYNnj7Xw5pa0zc72jpvB_rOW1fYbm2aNsDr3avez8dftyuk23EI_wN_QT5WpvH28-E-J0_fF4_z-2j54-5hfrOMipQzjLg0IsvLqpSQoczzEsAqpqyUBlJlRFoJlpsqxUIWqqykzJXiScmYylWal8jOyZe9bihHd329Nf1Ot6bW9zdLPcUAOZdc4p-Jvd6zXd_-Hq0f9Lb2hW0a42w7eq3CxDNMk-z_JCQSJDIZyKt_yE079i60rIOWSJjgMFGXB2rMt7Y8FvpmTwC-7YHnMOPdMY-gpzXQGz25rSe39bQG-nUN9IterB6mF_sLakuk2w</recordid><startdate>201110</startdate><enddate>201110</enddate><creator>Milh, Mathieu</creator><creator>Villeneuve, Nathalie</creator><creator>Chouchane, Mondher</creator><creator>Kaminska, Anna</creator><creator>Laroche, Cécile</creator><creator>Barthez, Marie Anne</creator><creator>Gitiaux, Cyril</creator><creator>Bartoli, Céline</creator><creator>Borges‐Correia, Ana</creator><creator>Cacciagli, Pierre</creator><creator>Mignon‐Ravix, Cécile</creator><creator>Cuberos, Hélène</creator><creator>Chabrol, Brigitte</creator><creator>Villard, Laurent</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><general>Wiley</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7TK</scope><scope>7X8</scope><scope>1XC</scope><orcidid>https://orcid.org/0000-0002-2190-6843</orcidid><orcidid>https://orcid.org/0000-0001-6657-5008</orcidid></search><sort><creationdate>201110</creationdate><title>Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations</title><author>Milh, Mathieu ; Villeneuve, Nathalie ; Chouchane, Mondher ; Kaminska, Anna ; Laroche, Cécile ; Barthez, Marie Anne ; Gitiaux, Cyril ; Bartoli, Céline ; Borges‐Correia, Ana ; Cacciagli, Pierre ; Mignon‐Ravix, Cécile ; Cuberos, Hélène ; Chabrol, Brigitte ; Villard, Laurent</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4631-68a75bdfd80518bbd00e939e88a049a74f73baf41c8c9df88b9962d339b94bd13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Age</topic><topic>Age of Onset</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Birth</topic><topic>Brain</topic><topic>Brain - pathology</topic><topic>Brain - physiopathology</topic><topic>Cortex</topic><topic>EEG</topic><topic>Electroencephalography</topic><topic>Encephalopathy</topic><topic>Encephalopathy Ohtahara</topic><topic>Epilepsy</topic><topic>Epilepsy - drug therapy</topic><topic>Epilepsy - genetics</topic><topic>Epilepsy - pathology</topic><topic>Epilepsy - physiopathology</topic><topic>Evolution</topic><topic>Evolutionary genetics</topic><topic>Genetic</topic><topic>Genetics</topic><topic>Genotype</topic><topic>Human health and pathology</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>Life Sciences</topic><topic>Magnetic Resonance Imaging</topic><topic>Movement disorders</topic><topic>Munc18 Proteins - genetics</topic><topic>Mutation</topic><topic>Neonates</topic><topic>Neuroimaging</topic><topic>Neurons and Cognition</topic><topic>NMR</topic><topic>Nuclear magnetic resonance</topic><topic>Oligonucleotide Array Sequence Analysis</topic><topic>Rhythms</topic><topic>Seizures</topic><topic>Suppression‐burst</topic><topic>Syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Milh, Mathieu</creatorcontrib><creatorcontrib>Villeneuve, Nathalie</creatorcontrib><creatorcontrib>Chouchane, Mondher</creatorcontrib><creatorcontrib>Kaminska, Anna</creatorcontrib><creatorcontrib>Laroche, Cécile</creatorcontrib><creatorcontrib>Barthez, Marie Anne</creatorcontrib><creatorcontrib>Gitiaux, Cyril</creatorcontrib><creatorcontrib>Bartoli, Céline</creatorcontrib><creatorcontrib>Borges‐Correia, Ana</creatorcontrib><creatorcontrib>Cacciagli, Pierre</creatorcontrib><creatorcontrib>Mignon‐Ravix, Cécile</creatorcontrib><creatorcontrib>Cuberos, Hélène</creatorcontrib><creatorcontrib>Chabrol, Brigitte</creatorcontrib><creatorcontrib>Villard, Laurent</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><jtitle>Epilepsia (Copenhagen)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Milh, Mathieu</au><au>Villeneuve, Nathalie</au><au>Chouchane, Mondher</au><au>Kaminska, Anna</au><au>Laroche, Cécile</au><au>Barthez, Marie Anne</au><au>Gitiaux, Cyril</au><au>Bartoli, Céline</au><au>Borges‐Correia, Ana</au><au>Cacciagli, Pierre</au><au>Mignon‐Ravix, Cécile</au><au>Cuberos, Hélène</au><au>Chabrol, Brigitte</au><au>Villard, Laurent</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations</atitle><jtitle>Epilepsia (Copenhagen)</jtitle><addtitle>Epilepsia</addtitle><date>2011-10</date><risdate>2011</risdate><volume>52</volume><issue>10</issue><spage>1828</spage><epage>1834</epage><pages>1828-1834</pages><issn>0013-9580</issn><eissn>1528-1167</eissn><eissn>1528-1157</eissn><coden>EPILAK</coden><abstract>Summary
Purpose: STXBP1 (MUNC18‐1) mutations have been associated with various types of epilepsies, mostly beginning early in life. To refine the phenotype associated with STXBP1 aberrations in early onset epileptic syndromes, we studied this gene in a cohort of patients with early onset epileptic encephalopathy.
Methods: STXBP1 was screened in a multicenter cohort of 52 patients with early onset epilepsy (first seizure observed before the age of 3 months), no cortical malformation on brain magnetic resonance imaging (MRI), and negative metabolic screening. Three groups of patients could be distinguished in this cohort: (1) Ohtahara syndromes (n = 38); (2) early myoclonic encephalopathies (n = 7); and (3) early onset epileptic encephalopathies that did not match any familiar syndrome (n = 7). None of the patients displayed any cortical malformation on brain MRI and all were screened through multiple video–electroencephalography (EEG) recordings for a time period spanning from birth to their sixth postnatal month. Subsequently, patients had standard EEG or video‐EEG recordings.
Key Findings: We found five novel STXBP1 mutations in patients for whom video‐EEG recordings could be sampled from the beginning of the disease. All patients with a mutation displayed Ohtahara syndrome, since most early seizures could be classified as epileptic spasms and since the silent EEG periods were on average shorter than bursts. However, each patient in addition displayed a particular clinical and EEG feature: In two patients, early seizures were clonic, with very early EEG studies exhibiting relatively low amplitude bursts of activity before progressing into a typical suppression‐burst pattern, whereas the three other patients displayed epileptic spasms associated with typical suppression‐burst patterns starting from the early recordings. Epilepsy dramatically improved after 6 months and finally disappeared before the end of the first year of life for four patients; the remaining one patient had few seizures until 18 months of age. In parallel, EEG paroxysmal abnormalities disappeared in three patients and decreased in two, giving place to continuous activity with fast rhythms. Each patient displayed frequent nonepileptic movement disorders that could easily be mistaken for epileptic seizures. These movements could be observed as early as the neonatal period and, unlike seizures, persisted during all the follow‐up period.
Significance: We confirm that STXBP1 is a major gene to screen in cases of Ohtahara syndrome, since it is mutated in >10% of the Ohtahara patients within our cohort. This gene should particularly be tested in the case of a surprising evolution of the patient condition if epileptic seizures and EEG paroxysmal activity disappear and are replaced by fast rhythms after the end of the first postnatal year.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>21770924</pmid><doi>10.1111/j.1528-1167.2011.03181.x</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-2190-6843</orcidid><orcidid>https://orcid.org/0000-0001-6657-5008</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0013-9580 |
ispartof | Epilepsia (Copenhagen), 2011-10, Vol.52 (10), p.1828-1834 |
issn | 0013-9580 1528-1167 1528-1157 |
language | eng |
recordid | cdi_hal_primary_oai_HAL_hal_01668681v1 |
source | Wiley |
subjects | Age Age of Onset Anticonvulsants - therapeutic use Birth Brain Brain - pathology Brain - physiopathology Cortex EEG Electroencephalography Encephalopathy Encephalopathy Ohtahara Epilepsy Epilepsy - drug therapy Epilepsy - genetics Epilepsy - pathology Epilepsy - physiopathology Evolution Evolutionary genetics Genetic Genetics Genotype Human health and pathology Humans Infant Infant, Newborn Life Sciences Magnetic Resonance Imaging Movement disorders Munc18 Proteins - genetics Mutation Neonates Neuroimaging Neurons and Cognition NMR Nuclear magnetic resonance Oligonucleotide Array Sequence Analysis Rhythms Seizures Suppression‐burst Syndrome |
title | Epileptic and nonepileptic features in patients with early onset epileptic encephalopathy and STXBP1 mutations |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T19%3A55%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_hal_p&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epileptic%20and%20nonepileptic%20features%20in%20patients%20with%20early%20onset%20epileptic%20encephalopathy%20and%20STXBP1%20mutations&rft.jtitle=Epilepsia%20(Copenhagen)&rft.au=Milh,%20Mathieu&rft.date=2011-10&rft.volume=52&rft.issue=10&rft.spage=1828&rft.epage=1834&rft.pages=1828-1834&rft.issn=0013-9580&rft.eissn=1528-1167&rft.coden=EPILAK&rft_id=info:doi/10.1111/j.1528-1167.2011.03181.x&rft_dat=%3Cproquest_hal_p%3E3278081061%3C/proquest_hal_p%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4631-68a75bdfd80518bbd00e939e88a049a74f73baf41c8c9df88b9962d339b94bd13%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1517237608&rft_id=info:pmid/21770924&rfr_iscdi=true |